{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:49Z","timestamp":1791821989488,"version":"4.3.4"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525005"],"award-info":[{"award-number":["82525005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20266"],"award-info":[{"award-number":["U22A20266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270363"],"award-info":[{"award-number":["82270363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300453"],"award-info":[{"award-number":["82300453"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0547302"],"award-info":[{"award-number":["2025ZD0547302"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0547100"],"award-info":[{"award-number":["2025ZD0547100"]}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2025EHA037"],"award-info":[{"award-number":["2025EHA037"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fibrosis, which is characterized by excessive extracellular matrix deposition and tissue stiffening, impairs organ function and particularly affects the heart, lungs, liver, and kidneys. The persistent activation of fibrosis-driving cells, such as myofibroblasts, lung epithelial cells, hepatic stellate cells and tubular epithelial cells, by various transcriptional cues and posttranslational modifications (PTMs) rewires cellular substrate metabolism, most notably glucose, amino acid and lipid flux, thereby recapitulating the Warburg effect originally described in cancer cells. Although the organ-specific mechanisms of fibrosis remain incompletely elucidated, different forms of fibrosis share common features of metabolic reprogramming. In this review, we first introduce the core metabolic pathways involved in fibrotic disorders including glycolysis, glutaminolysis and lipid metabolism. Next, we focus on organ-specific metabolic alterations and their regulatory mechanisms in fibrosis-related diseases, including those of the heart, lungs, liver, kidneys, skin, peritoneum and glands, and discuss their underlying mechanisms: altered enzyme expression, subcellular localization and PTMs, within each organ-specific context. In addition to their canonical catalytic functions, enzymes that participate in glucose and lipid metabolism influence fibrosis through nonenzymatic activities mediated by PTMs, including phosphorylation, acetylation, ubiquitination, and the newly recognized lactylation. We further summarize mechanistic insights across organs and metabolic crosstalk in fibrosis. Finally, we discuss the current clinical translation and applications of these pathways. This review provides a reference for further research on metabolic reprogramming, highlights the role of aberrant metabolism and its underlying mechanisms in fibrosis across organs, and identifies emerging therapeutic strategies targeting glycolysis and lipid metabolism.<\/jats:p>","DOI":"10.1186\/s43556-026-00490-9","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:35:38Z","timestamp":1780659338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeutics"],"prefix":"10.1186","volume":"7","author":[{"given":"Yourong","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Joy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5080-9383","authenticated-orcid":false,"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"490_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biom15091273","author":"Q Deng","year":"2025","unstructured":"Deng Q, Wu L, Zhang C, Dang M. Global fibrosis burden and a transcriptional biomarker-based strategy for early detection in resource-limited settings. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15091273.","journal-title":"Biomolecules"},{"issue":"1","key":"490_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","volume":"19","author":"X Zhao","year":"2020","unstructured":"Zhao X, Kwan JYY, Yip K, Liu PP, Liu FF. Targeting metabolic dysregulation for fibrosis therapy. Nat Rev Drug Discov. 2020;19(1):57\u201375. https:\/\/doi.org\/10.1038\/s41573-019-0040-5.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"490_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41536-024-00359-x","volume":"9","author":"A Noom","year":"2024","unstructured":"Noom A, Sawitzki B, Knaus P, Duda GN. A two-way street - cellular metabolism and myofibroblast contraction. npj Regen Med. 2024;9(1):15. https:\/\/doi.org\/10.1038\/s41536-024-00359-x.","journal-title":"npj Regen Med"},{"key":"490_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00716-0","author":"FS Younesi","year":"2024","unstructured":"Younesi FS, Miller AE, Barker TH, Rossi FMV, Hinz B. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat Rev Mol Cell Biol. 2024. https:\/\/doi.org\/10.1038\/s41580-024-00716-0.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"490_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tem.2021.05.003","volume":"32","author":"J Henderson","year":"2021","unstructured":"Henderson J, O\u2019Reilly S. The emerging role of metabolism in fibrosis. Trends Endocrinol Metab. 2021;32(8):639\u201353. https:\/\/doi.org\/10.1016\/j.tem.2021.05.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"490_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407134","volume":"12","author":"W Sun","year":"2025","unstructured":"Sun W, Zhou S, Peng L, Wang W, Liu Y, Wang T, et al. Fatty Acid Oxidation-Glycolysis Metabolic Transition Affects ECM Homeostasis in Silica-Induced Pulmonary Fibrosis. Adv Sci (Weinh). 2025;12(7):e2407134. https:\/\/doi.org\/10.1002\/advs.202407134.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"490_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1210\/endrev\/bnab038","volume":"43","author":"B Stocks","year":"2022","unstructured":"Stocks B, Zierath JR. Post-translational modifications: the signals at the intersection of exercise, glucose uptake, and insulin sensitivity. Endocr Rev. 2022;43(4):654\u201377. https:\/\/doi.org\/10.1210\/endrev\/bnab038.","journal-title":"Endocr Rev"},{"key":"490_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-026-00417-4","author":"Z Liu","year":"2026","unstructured":"Liu Z, Li A, Ma Z, Wang J, Chen X, Wang Z, et al. Lactate metabolism and protein lactylation in cancer. Mol Biomed. 2026. https:\/\/doi.org\/10.1186\/s43556-026-00417-4.","journal-title":"Mol Biomed"},{"key":"490_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-026-01361-9","author":"W Zhang","year":"2026","unstructured":"Zhang W, Zhu X, Zhang Y, Yang J, Sun X, Wang J, et al. Lactylation: a metabolic-epigenetic bridge in diabetic kidney disease and a therapeutic target for TCM. Chin Med. 2026. https:\/\/doi.org\/10.1186\/s13020-026-01361-9.","journal-title":"Chin Med"},{"issue":"10","key":"490_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.tem.2022.07.004","volume":"33","author":"M Certo","year":"2022","unstructured":"Certo M, Llibre A, Lee W, Mauro C. Understanding lactate sensing and signalling. Trends Endocrinol Metab. 2022;33(10):722\u201335. https:\/\/doi.org\/10.1016\/j.tem.2022.07.004.","journal-title":"Trends Endocrinol Metab"},{"key":"490_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.07.003","volume":"207","author":"ZY Liu","year":"2023","unstructured":"Liu ZY, Song K, Tu B, Lin LC, Sun H, Zhou Y, et al. Glycolytic reprogramming in organ fibrosis: new dynamics of the epigenetic landscape. Free Radic Biol Med. 2023;207:1\u201310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.07.003.","journal-title":"Free Radic Biol Med"},{"key":"490_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/jci186420","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, Carpentier AC, Wang D. MASH: the nexus of metabolism, inflammation, and fibrosis. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/jci186420.","journal-title":"J Clin Invest"},{"key":"490_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040535","author":"NS Chandel","year":"2021","unstructured":"Chandel NS. Glycolysis. Cold Spring Harb Perspect Biol. 2021. https:\/\/doi.org\/10.1101\/cshperspect.a040535.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"490_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41569-025-01165-8","volume":"22","author":"I Andreadou","year":"2025","unstructured":"Andreadou I, Ghigo A, Nikolaou PE, Swirski FK, Thackeray JT, Heusch G, et al. Immunometabolism in heart failure. Nat Rev Cardiol. 2025;22(10):751\u201372. https:\/\/doi.org\/10.1038\/s41569-025-01165-8.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"490_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.tcb.2022.02.003","volume":"32","author":"X Bian","year":"2022","unstructured":"Bian X, Jiang H, Meng Y, Li YP, Fang J, Lu Z. Regulation of gene expression by glycolytic and gluconeogenic enzymes. Trends Cell Biol. 2022;32(9):786\u201399. https:\/\/doi.org\/10.1016\/j.tcb.2022.02.003.","journal-title":"Trends Cell Biol"},{"issue":"7","key":"490_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab. 2024;36(7):1439\u201355. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.003.","journal-title":"Cell Metab"},{"issue":"16","key":"490_CR17","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","volume":"120","author":"Q Sun","year":"2024","unstructured":"Sun Q, Karwi QG, Wong N, Lopaschuk GD. Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond. Cardiovasc Res. 2024;120(16):1996\u20132016. https:\/\/doi.org\/10.1093\/cvr\/cvae231.","journal-title":"Cardiovasc Res"},{"issue":"14","key":"490_CR18","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.7150\/ijms.118338","volume":"22","author":"H Luo","year":"2025","unstructured":"Luo H, Guo S, Chu Y, Xin Y, Yin X, Li X. Metabolism and Targeted Therapy of Fibrosis in Chronic Pancreatitis: A Review. Int J Med Sci. 2025;22(14):3528\u201342. https:\/\/doi.org\/10.7150\/ijms.118338.","journal-title":"Int J Med Sci"},{"issue":"21","key":"490_CR19","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1161\/circulationaha.121.057879","volume":"145","author":"AA Gibb","year":"2022","unstructured":"Gibb AA, Murray EK, Huynh AT, Gaspar RB, Ploesch TL, Bedi K, et al. Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure. Circulation. 2022;145(21):1625\u20138. https:\/\/doi.org\/10.1161\/circulationaha.121.057879.","journal-title":"Circulation"},{"issue":"7","key":"490_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70120","volume":"6","author":"MA Kumar","year":"2025","unstructured":"Kumar MA, Baba SK, Khan IR, Khan MS, Husain FM, Ahmad S, et al. Glutamine metabolism: molecular regulation, biological functions, and diseases. MedComm (2020). 2025;6(7):e70120. https:\/\/doi.org\/10.1002\/mco2.70120.","journal-title":"MedComm (2020)"},{"issue":"1","key":"490_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11(1):102. https:\/\/doi.org\/10.1038\/s41467-019-13668-3.","journal-title":"Nat Commun"},{"issue":"17","key":"490_CR22","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/cvr\/cvae248","volume":"120","author":"KA Alhasan","year":"2024","unstructured":"Alhasan KA, King MA, Pattar BSB, Lewis IA, Lopaschuk GD, Greenway SC. Anaplerotic filling in heart failure: a review of mechanism and potential therapeutics. Cardiovasc Res. 2024;120(17):2166\u201378. https:\/\/doi.org\/10.1093\/cvr\/cvae248.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"490_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-025-01186-y","volume":"32","author":"S Sarkar","year":"2025","unstructured":"Sarkar S, Chang CI, Jean J, Wu MJ. TCA cycle-derived oncometabolites in cancer and the immune microenvironment. J Biomed Sci. 2025;32(1):87. https:\/\/doi.org\/10.1186\/s12929-025-01186-y.","journal-title":"J Biomed Sci"},{"issue":"1","key":"490_CR24","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1186\/s12967-025-07088-9","volume":"23","author":"R Ma","year":"2025","unstructured":"Ma R, Lu D, Yang Z, Ji X, Tian R, Xu F, et al. Emerging therapy strategies for energy metabolism in acute myocardial infarction. J Transl Med. 2025;23(1):1140. https:\/\/doi.org\/10.1186\/s12967-025-07088-9.","journal-title":"J Transl Med"},{"issue":"1","key":"490_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41420-025-02554-1","volume":"11","author":"Y Lei","year":"2025","unstructured":"Lei Y, Cai S, Zhang JK, Ding SQ, Zhang ZH, Zhang CD, et al. The role and mechanism of fatty acid oxidation in cancer drug resistance. Cell Death Discov. 2025;11(1):277. https:\/\/doi.org\/10.1038\/s41420-025-02554-1.","journal-title":"Cell Death Discov"},{"issue":"8","key":"490_CR26","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41375-025-02645-z","volume":"39","author":"V Dembitz","year":"2025","unstructured":"Dembitz V, James SC, Gallipoli P. Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities. Leukemia. 2025;39(8):1814\u201323. https:\/\/doi.org\/10.1038\/s41375-025-02645-z.","journal-title":"Leukemia"},{"issue":"1","key":"490_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, Liu CH, Lei M, Zeng Q, Li L, Tang H, et al. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 2024;9(1):268. https:\/\/doi.org\/10.1038\/s41392-024-01954-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"490_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther. 2022;7(1):206. https:\/\/doi.org\/10.1038\/s41392-022-01070-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"490_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tem.2023.10.004","volume":"35","author":"LC Lin","year":"2024","unstructured":"Lin LC, Liu ZY, Yang JJ, Zhao JY, Tao H. Lipid metabolism reprogramming in cardiac fibrosis. Trends Endocrinol Metab. 2024;35(2):164\u201375. https:\/\/doi.org\/10.1016\/j.tem.2023.10.004.","journal-title":"Trends Endocrinol Metab"},{"key":"490_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2025.01.001","volume":"228","author":"P Liu","year":"2025","unstructured":"Liu P, Liu ZY, Mao S, Shen XY, Liu ZY, Lin LC, et al. Targeted mitochondrial function for cardiac fibrosis: An epigenetic perspective. Free Radic Biol Med. 2025;228:163\u201372. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.01.001.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"490_CR31","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1111\/bph.12363","volume":"171","author":"R Nederlof","year":"2014","unstructured":"Nederlof R, Eerbeek O, Hollmann MW, Southworth R, Zuurbier CJ. Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart. Br J Pharmacol. 2014;171(8):2067\u201379. https:\/\/doi.org\/10.1111\/bph.12363.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"490_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.112.005645","volume":"2","author":"P Pasdois","year":"2012","unstructured":"Pasdois P, Parker JE, Halestrap AP. Extent of mitochondrial hexokinase II dissociation during ischemia correlates with mitochondrial cytochrome c release, reactive oxygen species production, and infarct size on reperfusion. J Am Heart Assoc. 2012;2(1):e005645. https:\/\/doi.org\/10.1161\/jaha.112.005645.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"490_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00395-023-01018-w","volume":"118","author":"S Chen","year":"2023","unstructured":"Chen S, Zou Y, Song C, Cao K, Cai K, Wu Y, et al. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Res Cardiol. 2023;118(1):48. https:\/\/doi.org\/10.1007\/s00395-023-01018-w.","journal-title":"Basic Res Cardiol"},{"issue":"11","key":"490_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21217","volume":"9","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cheng X, Wang Y, Guo H, Song Y, Wang H, et al. Phlorizin ameliorates myocardial fibrosis by inhibiting pyroptosis through restraining HK1-mediated NLRP3 inflammasome activation. Heliyon. 2023;9(11):e21217. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21217.","journal-title":"Heliyon"},{"issue":"6","key":"490_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000355","volume":"2","author":"KS McCommis","year":"2013","unstructured":"McCommis KS, Douglas DL, Krenz M, Baines CP. Cardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway flux. J Am Heart Assoc. 2013;2(6):e000355. https:\/\/doi.org\/10.1161\/jaha.113.000355.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"490_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/emmm.201200240","volume":"4","author":"R Wu","year":"2012","unstructured":"Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, et al. Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med. 2012;4(7):633\u201346. https:\/\/doi.org\/10.1002\/emmm.201200240.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"490_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00109-023-02323-6","volume":"101","author":"F Wang","year":"2023","unstructured":"Wang F, Yin X, Fan YM, Zhang X, Ma C, Jia K, et al. Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction. J Mol Med (Berl). 2023;101(6):743\u201356. https:\/\/doi.org\/10.1007\/s00109-023-02323-6.","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"490_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05403-6","volume":"13","author":"X Zou","year":"2022","unstructured":"Zou X, Ouyang H, Lin F, Zhang H, Yang Y, Pang D, et al. MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis. Cell Death Dis. 2022;13(11):948. https:\/\/doi.org\/10.1038\/s41419-022-05403-6.","journal-title":"Cell Death Dis"},{"issue":"8","key":"490_CR39","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/jcp.30790","volume":"237","author":"X He","year":"2022","unstructured":"He X, Zeng H, Cantrell AC, Williams QA, Chen JX. Knockout of TIGAR enhances myocardial phosphofructokinase activity and preserves diastolic function in heart failure. J Cell Physiol. 2022;237(8):3317\u201327. https:\/\/doi.org\/10.1002\/jcp.30790.","journal-title":"J Cell Physiol"},{"key":"490_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042433","author":"X He","year":"2024","unstructured":"He X, Williams QA, Cantrell AC, Besanson J, Zeng H, Chen JX. TIGAR deficiency blunts Angiotensin-II-induced cardiac hypertrophy in mice. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25042433.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"490_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36712-9","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Qiao S, Zhao Y, Tian H, Yan W, Hou X, et al. The KLF7\/PFKL\/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice. Nat Commun. 2023;14(1):959. https:\/\/doi.org\/10.1038\/s41467-023-36712-9.","journal-title":"Nat Commun"},{"issue":"1","key":"490_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/jcp.30536","volume":"237","author":"YB Lee","year":"2022","unstructured":"Lee YB, Min JK, Kim JG, Cap KC, Islam R, Hossain AJ, et al. Multiple functions of pyruvate kinase M2 in various cell types. J Cell Physiol. 2022;237(1):128\u201348. https:\/\/doi.org\/10.1002\/jcp.30536.","journal-title":"J Cell Physiol"},{"issue":"4","key":"490_CR43","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41418-020-00669-9","volume":"28","author":"L Hauck","year":"2021","unstructured":"Hauck L, Dadson K, Chauhan S, Grothe D, Billia F. Inhibiting the Pkm2\/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI. Cell Death Differ. 2021;28(4):1398\u2013417. https:\/\/doi.org\/10.1038\/s41418-020-00669-9.","journal-title":"Cell Death Differ"},{"issue":"15","key":"490_CR44","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/circulationaha.119.043067","volume":"141","author":"A Magadum","year":"2020","unstructured":"Magadum A, Singh N, Kurian AA, Munir I, Mehmood T, Brown K, et al. Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration. Circulation. 2020;141(15):1249\u201365. https:\/\/doi.org\/10.1161\/circulationaha.119.043067.","journal-title":"Circulation"},{"issue":"11","key":"490_CR45","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1016\/j.apsb.2021.03.021","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Liu L, Zheng Q, Hao H, Ye H, Li P, et al. Protocatechuic aldehyde protects cardiomycoytes against ischemic injury via regulation of nuclear pyruvate kinase M2. Acta Pharmaceutica Sinica B. 2021;11(11):3553\u201366. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.021.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"490_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144935","author":"S Sharma","year":"2021","unstructured":"Sharma S, Watanabe T, Nishimoto T, Takihara T, Mlakar L, Nguyen XX, et al. E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.144935.","journal-title":"JCI Insight"},{"issue":"22","key":"490_CR47","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.1111\/jcmm.17007","volume":"25","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zheng C, Gao Z, Wang L, Chen C, Zheng Y, et al. PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-\u03b2\/Smad2\/3 and Jak2\/Stat3 pathways through oxidative stress. J Cell Mol Med. 2021;25(22):10711\u201323. https:\/\/doi.org\/10.1111\/jcmm.17007.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"490_CR48","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.121.024854","volume":"11","author":"L Ni","year":"2022","unstructured":"Ni L, Lin B, Hu L, Zhang R, Fu F, Shen M, et al. Pyruvate kinase M2 protects heart from pressure overload-induced heart failure by phosphorylating RAC1. J Am Heart Assoc. 2022;11(11):e024854. https:\/\/doi.org\/10.1161\/jaha.121.024854.","journal-title":"J Am Heart Assoc"},{"issue":"669","key":"490_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm3565","volume":"14","author":"MA Lorenzana-Carrillo","year":"2022","unstructured":"Lorenzana-Carrillo MA, Gopal K, Byrne NJ, Tejay S, Saleme B, Das SK, et al. TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4\/6 and induces P53 in cardiomyocytes to promote heart failure. Sci Transl Med. 2022;14(669):eabm3565. https:\/\/doi.org\/10.1126\/scitranslmed.abm3565.","journal-title":"Sci Transl Med"},{"issue":"12","key":"490_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2127-7","volume":"10","author":"J Zhou","year":"2019","unstructured":"Zhou J, Zhang S, Chen Z, He Z, Xu Y, Li Z. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death Dis. 2019;10(12):885. https:\/\/doi.org\/10.1038\/s41419-019-2127-7.","journal-title":"Cell Death Dis"},{"issue":"9","key":"490_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166441","volume":"1868","author":"JJ Ji","year":"2022","unstructured":"Ji JJ, Qian LL, Zhu Y, Jiang Y, Guo JQ, Wu Y, et al. Kallistatin\/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activation. Biochim Biophys Acta Mol Basis Dis. 2022;1868(9):166441. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166441.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"490_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ebiom.2019.08.045","volume":"47","author":"Y Wu","year":"2019","unstructured":"Wu Y, Qin YH, Liu Y, Zhu L, Zhao XX, Liu YY, et al. Cardiac troponin I autoantibody induces myocardial dysfunction by PTEN signaling activation. EBioMedicine. 2019;47:329\u201340. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.045.","journal-title":"EBioMedicine"},{"issue":"5","key":"490_CR53","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/andr.13359","volume":"11","author":"R Iida-Norita","year":"2023","unstructured":"Iida-Norita R, Miyata H, Kaneda Y, Emori C, Noda T, Nakagawa T, et al. Generation of humanized LDHC knock-in mice as a tool to assess human LDHC-targeting contraceptive drugs. Andrology. 2023;11(5):840\u20138. https:\/\/doi.org\/10.1111\/andr.13359.","journal-title":"Andrology"},{"key":"490_CR54","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma D, Singh M, Rani R. Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics. Semin Cancer Biol. 2022;87:184\u201395. https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.007.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"490_CR55","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.molcel.2020.12.012","volume":"81","author":"A Luengo","year":"2021","unstructured":"Luengo A, Li Z, Gui DY, Sullivan LB, Zagorulya M, Do BT, et al. Increased demand for NAD(+) relative to ATP drives aerobic glycolysis. Mol Cell. 2021;81(4):691-707.e696. https:\/\/doi.org\/10.1016\/j.molcel.2020.12.012.","journal-title":"Mol Cell"},{"issue":"1","key":"490_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04842-9","volume":"22","author":"H Gong","year":"2024","unstructured":"Gong H, Zhong H, Cheng L, Li LP, Zhang DK. Post-translational protein lactylation modification in health and diseases: a double-edged sword. J Transl Med. 2024;22(1):41. https:\/\/doi.org\/10.1186\/s12967-023-04842-9.","journal-title":"J Transl Med"},{"issue":"4","key":"490_CR57","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/s0008-6363(02)00809-x","volume":"57","author":"A Baartscheer","year":"2003","unstructured":"Baartscheer A, Schumacher CA, van Borren MM, Belterman CN, Coronel R, Fiolet JW. Increased Na+\/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res. 2003;57(4):1015\u201324. https:\/\/doi.org\/10.1016\/s0008-6363(02)00809-x.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"490_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069129","volume":"13","author":"H Li","year":"2023","unstructured":"Li H, Chen J, Xing X, Lou D. Association of lactate detection with in-hospital mortality in critically ill patients with acute myocardial infarction: a retrospective cohort study. BMJ Open. 2023;13(4):e069129. https:\/\/doi.org\/10.1136\/bmjopen-2022-069129.","journal-title":"BMJ Open"},{"issue":"5","key":"490_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9465","volume":"9","author":"M Fan","year":"2023","unstructured":"Fan M, Yang K, Wang X, Chen L, Gill PS, Ha T, et al. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci Adv. 2023;9(5):eadc9465. https:\/\/doi.org\/10.1126\/sciadv.adc9465.","journal-title":"Sci Adv"},{"issue":"11","key":"490_CR60","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/circresaha.122.320488","volume":"131","author":"N Wang","year":"2022","unstructured":"Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, et al. Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ Res. 2022;131(11):893\u2013908. https:\/\/doi.org\/10.1161\/circresaha.122.320488.","journal-title":"Circ Res"},{"issue":"1","key":"490_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13578-023-01098-0","volume":"13","author":"T Wei","year":"2023","unstructured":"Wei T, Guo Y, Huang C, Sun M, Zhou B, Gao J, et al. Fibroblast-to-cardiomyocyte lactate shuttle modulates hypertensive cardiac remodelling. Cell Biosci. 2023;13(1):151. https:\/\/doi.org\/10.1186\/s13578-023-01098-0.","journal-title":"Cell Biosci"},{"issue":"4","key":"490_CR62","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.18632\/aging.102818","volume":"12","author":"A Gizak","year":"2020","unstructured":"Gizak A, McCubrey JA, Rakus D. Cell-to-cell lactate shuttle operates in heart and is important in age-related heart failure. Aging (Albany NY). 2020;12(4):3388\u2013406. https:\/\/doi.org\/10.18632\/aging.102818.","journal-title":"Aging (Albany NY)"},{"key":"490_CR63","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.ijbiomac.2019.11.136","volume":"155","author":"Z Hou","year":"2020","unstructured":"Hou Z, Yan W, Li T, Wu W, Cui Y, Zhang X, et al. Lactic acid-mediated endothelial to mesenchymal transition through TGF-\u03b21 contributes to in-stent stenosis in poly-L-lactic acid stent. Int J Biol Macromol. 2020;155:1589\u201398. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.11.136.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"490_CR64","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41422-023-00844-w","volume":"33","author":"N Zhang","year":"2023","unstructured":"Zhang N, Zhang Y, Xu J, Wang P, Wu B, Lu S, et al. \u03b1-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure. Cell Res. 2023;33(9):679\u201398. https:\/\/doi.org\/10.1038\/s41422-023-00844-w.","journal-title":"Cell Res"},{"issue":"8","key":"490_CR65","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s12276-024-01309-9","volume":"56","author":"L Du","year":"2024","unstructured":"Du L, Wang X, Guo Y, Tao T, Wu H, Xu X, et al. Altered lipid metabolism promoting cardiac fibrosis is mediated by CD34(+) cell-derived FABP4(+) fibroblasts. Exp Mol Med. 2024;56(8):1869\u201386. https:\/\/doi.org\/10.1038\/s12276-024-01309-9.","journal-title":"Exp Mol Med"},{"issue":"2","key":"490_CR66","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00011.2023","volume":"104","author":"JFC Glatz","year":"2024","unstructured":"Glatz JFC, Heather LC, Luiken J. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Physiol Rev. 2024;104(2):727\u201364. https:\/\/doi.org\/10.1152\/physrev.00011.2023.","journal-title":"Physiol Rev"},{"issue":"1","key":"490_CR67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41401-022-00934-2","volume":"44","author":"HF Wang","year":"2023","unstructured":"Wang HF, Wang YX, Zhou YP, Wei YP, Yan Y, Zhang ZJ, et al. Protein O-GlcNAcylation in cardiovascular diseases. Acta Pharmacol Sin. 2023;44(1):8\u201318. https:\/\/doi.org\/10.1038\/s41401-022-00934-2.","journal-title":"Acta Pharmacol Sin"},{"key":"490_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102878","volume":"95","author":"K Zhao","year":"2025","unstructured":"Zhao K, Yan L, Sun X, Hu X. O-GlcNAc transferase-mediated O-GlcNAcylation of CD36 against myocardial ischemia-reperfusion injury. Tissue Cell. 2025;95:102878. https:\/\/doi.org\/10.1016\/j.tice.2025.102878.","journal-title":"Tissue Cell"},{"issue":"1","key":"490_CR69","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.1038\/s41467-025-61875-y","volume":"16","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Li J, Liu X, Chen X, Zhu L, Zhang Z, et al. Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy. Nat Commun. 2025;16(1):6602. https:\/\/doi.org\/10.1038\/s41467-025-61875-y.","journal-title":"Nat Commun"},{"issue":"9","key":"490_CR70","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ejhf.3347","volume":"26","author":"PM Seferovi\u0107","year":"2024","unstructured":"Seferovi\u0107 PM, Paulus WJ, Rosano G, Polovina M, Petrie MC, Jhund PS, et al. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. Eur J Heart Fail. 2024;26(9):1893\u2013903. https:\/\/doi.org\/10.1002\/ejhf.3347.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"490_CR71","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/circresaha.123.322910","volume":"134","author":"S Wang","year":"2024","unstructured":"Wang S, Han Y, Liu R, Hou M, Neumann D, Zhang J, et al. Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis. Circ Res. 2024;134(5):505\u201325. https:\/\/doi.org\/10.1161\/circresaha.123.322910.","journal-title":"Circ Res"},{"issue":"12","key":"490_CR72","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/circresaha.124.325918","volume":"136","author":"K Dennis","year":"2025","unstructured":"Dennis K, Gopal K, Montes Aparicio CN, Zhang JA, Castro-Guarda M, Nicol T, et al. FoxO1-zDHHC4-CD36 S-acylation axis drives metabolic dysfunction in Diabetes. Circ Res. 2025;136(12):1545\u201360. https:\/\/doi.org\/10.1161\/circresaha.124.325918.","journal-title":"Circ Res"},{"issue":"7","key":"490_CR73","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s44161-024-00502-3","volume":"3","author":"MP Lazaropoulos","year":"2024","unstructured":"Lazaropoulos MP, Gibb AA, Chapski DJ, Nair AA, Reiter AN, Roy R, et al. Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program. Nat Cardiovasc Res. 2024;3(7):869\u201382. https:\/\/doi.org\/10.1038\/s44161-024-00502-3.","journal-title":"Nat Cardiovasc Res"},{"issue":"6","key":"490_CR74","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/hypertensionaha.124.24088","volume":"82","author":"N Kuwahara","year":"2025","unstructured":"Kuwahara N, Nagao M, Shinohara M, Kaneshiro K, Emoto T, Yoshida T, et al. ACLY promotes cardiac fibrosis via the regulation of DNL and histone acetylation. Hypertension. 2025;82(6):1116\u201328. https:\/\/doi.org\/10.1161\/hypertensionaha.124.24088.","journal-title":"Hypertension"},{"key":"490_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-025-02192-z","author":"Y Li","year":"2025","unstructured":"Li Y, Lou Z, Liu F, Liu Y, Wang C, Wang Y, et al. The impact of lipid metabolism on ferroptosis in myocardial ischemia-reperfusion injury. Apoptosis. 2025. https:\/\/doi.org\/10.1007\/s10495-025-02192-z.","journal-title":"Apoptosis"},{"issue":"9","key":"490_CR76","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic Pulmonary Fibrosis (an update) and Progressive Pulmonary Fibrosis in adults: An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"490_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1608750","volume":"13","author":"T Dai","year":"2025","unstructured":"Dai T, Liang Y, Li X, Zhao J, Li G, Li Q, et al. Targeting alveolar epithelial cell metabolism in pulmonary fibrosis: pioneering an emerging therapeutic strategy. Front Cell Dev Biol. 2025;13:1608750. https:\/\/doi.org\/10.3389\/fcell.2025.1608750.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"490_CR78","doi-asserted-by":"publisher","first-page":"C689","DOI":"10.1152\/ajpcell.00586.2020","volume":"320","author":"W Roque","year":"2021","unstructured":"Roque W, Romero F. Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids. Am J Physiol Cell Physiol. 2021;320(5):C689-c695. https:\/\/doi.org\/10.1152\/ajpcell.00586.2020.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"490_CR79","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2967\/jnumed.115.163360","volume":"56","author":"Y Umeda","year":"2015","unstructured":"Umeda Y, Demura Y, Morikawa M, Anzai M, Kadowaki M, Ameshima S, et al. Prognostic value of dual-time-point 18F-FDG PET for Idiopathic Pulmonary Fibrosis. J Nucl Med. 2015;56(12):1869\u201375. https:\/\/doi.org\/10.2967\/jnumed.115.163360.","journal-title":"J Nucl Med"},{"key":"490_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010315","author":"P Yan","year":"2023","unstructured":"Yan P, Liu J, Li Z, Wang J, Zhu Z, Wang L, et al. Glycolysis reprogramming in Idiopathic Pulmonary Fibrosis: unveiling the mystery of lactate in the lung. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms25010315.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"490_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01866-x","volume":"22","author":"DA Newton","year":"2021","unstructured":"Newton DA, Lottes RG, Ryan RM, Spyropoulos DD, Baatz JE. Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue. Respir Res. 2021;22(1):278. https:\/\/doi.org\/10.1186\/s12931-021-01866-x.","journal-title":"Respir Res"},{"issue":"1","key":"490_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02331-7","volume":"24","author":"X Rao","year":"2023","unstructured":"Rao X, Zhou D, Deng H, Chen Y, Wang J, Zhou X, et al. Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury. Respir Res. 2023;24(1):25. https:\/\/doi.org\/10.1186\/s12931-023-02331-7.","journal-title":"Respir Res"},{"key":"490_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.132582","volume":"461","author":"P Wang","year":"2024","unstructured":"Wang P, Xie D, Xiao T, Cheng C, Wang D, Sun J, et al. H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1\/m6A\/NREP. J Hazard Mater. 2024;461:132582. https:\/\/doi.org\/10.1016\/j.jhazmat.2023.132582.","journal-title":"J Hazard Mater"},{"issue":"19","key":"490_CR84","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.7150\/thno.60385","volume":"11","author":"G Satyanarayana","year":"2021","unstructured":"Satyanarayana G, Turaga RC, Sharma M, Wang S, Mishra F, Peng G, et al. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts. Theranostics. 2021;11(19):9331\u201341. https:\/\/doi.org\/10.7150\/thno.60385.","journal-title":"Theranostics"},{"key":"490_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102160","volume":"47","author":"C van de Wetering","year":"2021","unstructured":"van de Wetering C, Manuel AM, Sharafi M, Aboushousha R, Qian X, Erickson C, et al. Glutathione-S-transferase P promotes glycolysis in asthma in association with oxidation of pyruvate kinase M2. Redox Biol. 2021;47:102160. https:\/\/doi.org\/10.1016\/j.redox.2021.102160.","journal-title":"Redox Biol"},{"issue":"14","key":"490_CR86","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.7150\/thno.72328","volume":"12","author":"S Mei","year":"2022","unstructured":"Mei S, Xu Q, Hu Y, Tang R, Feng J, Zhou Y, et al. Integrin \u03b23-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis. Theranostics. 2022;12(14):6057\u201368. https:\/\/doi.org\/10.7150\/thno.72328.","journal-title":"Theranostics"},{"issue":"6","key":"490_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1308","volume":"13","author":"X Gu","year":"2023","unstructured":"Gu X, Meng H, Peng C, Lin S, Li B, Zhao L, et al. Inflammasome activation and metabolic remodelling in p16-positive aging cells aggravates high-fat diet-induced lung fibrosis by inhibiting NEDD4L-mediated K48-polyubiquitin-dependent degradation of SGK1. Clin Transl Med. 2023;13(6):e1308. https:\/\/doi.org\/10.1002\/ctm2.1308.","journal-title":"Clin Transl Med"},{"issue":"11","key":"490_CR88","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1096\/fj.201600428R","volume":"30","author":"M Andrianifahanana","year":"2016","unstructured":"Andrianifahanana M, Hernandez DM, Yin X, Kang JH, Jung MY, Wang Y, et al. Profibrotic up-regulation of glucose transporter 1 by TGF-\u03b2 involves activation of MEK and mammalian target of rapamycin complex 2 pathways. Faseb j. 2016;30(11):3733\u201344. https:\/\/doi.org\/10.1096\/fj.201600428R.","journal-title":"Faseb j"},{"issue":"4","key":"490_CR89","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1165\/rcmb.2016-0225OC","volume":"56","author":"SJ Cho","year":"2017","unstructured":"Cho SJ, Moon JS, Lee CM, Choi AM, Stout-Delgado HW. Glucose Transporter 1-Dependent Glycolysis Is Increased during Aging-Related Lung Fibrosis, and Phloretin Inhibits Lung Fibrosis. Am J Respir Cell Mol Biol. 2017;56(4):521\u201331. https:\/\/doi.org\/10.1165\/rcmb.2016-0225OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"490_CR90","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.7150\/ijbs.57915","volume":"17","author":"Q Xu","year":"2021","unstructured":"Xu Q, Cheng D, Li G, Liu Y, Li P, Sun W, et al. CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p\/FOXK2-dependent manner. Int J Biol Sci. 2021;17(9):2294\u2013307. https:\/\/doi.org\/10.7150\/ijbs.57915.","journal-title":"Int J Biol Sci"},{"key":"490_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109985","volume":"117","author":"J Zhang","year":"2023","unstructured":"Zhang J, Chen W, Du J, Chu L, Zhou Z, Zhong W, et al. RNF130 protects against pulmonary fibrosis through suppressing aerobic glycolysis by mediating c-myc ubiquitination. Int Immunopharmacol. 2023;117:109985. https:\/\/doi.org\/10.1016\/j.intimp.2023.109985.","journal-title":"Int Immunopharmacol"},{"key":"490_CR92","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aax4067","author":"X Yin","year":"2019","unstructured":"Yin X, Choudhury M, Kang JH, Schaefbauer KJ, Jung MY, Andrianifahanana M, et al. Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-\u03b2. Sci Signal. 2019. https:\/\/doi.org\/10.1126\/scisignal.aax4067.","journal-title":"Sci Signal"},{"issue":"2","key":"490_CR93","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jpha.2023.09.008","volume":"14","author":"B Shan","year":"2024","unstructured":"Shan B, Zhou H, Guo C, Liu X, Wu M, Zhai R, et al. Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using (13)C metabolic flux analysis. J Pharm Anal. 2024;14(2):244\u201358. https:\/\/doi.org\/10.1016\/j.jpha.2023.09.008.","journal-title":"J Pharm Anal"},{"issue":"6","key":"490_CR94","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41374-020-0404-9","volume":"100","author":"X Hu","year":"2020","unstructured":"Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H, et al. PI3K-Akt-mTOR\/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest. 2020;100(6):801\u201311. https:\/\/doi.org\/10.1038\/s41374-020-0404-9.","journal-title":"Lab Invest"},{"key":"490_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.744826","volume":"12","author":"W Chen","year":"2021","unstructured":"Chen W, Zhang J, Zhong W, Liu Y, Lu Y, Zeng Z, et al. Anlotinib inhibits PFKFB3-driven glycolysis in myofibroblasts to reverse pulmonary fibrosis. Front Pharmacol. 2021;12:744826. https:\/\/doi.org\/10.3389\/fphar.2021.744826.","journal-title":"Front Pharmacol"},{"issue":"1","key":"490_CR96","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12967-022-03837-2","volume":"21","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang Y, Huang W, Yuan Y, Hong Q, Xie Z, et al. Alamandine\/MrgD axis prevents TGF-\u03b21-mediated fibroblast activation via regulation of aerobic glycolysis and mitophagy. J Transl Med. 2023;21(1):24. https:\/\/doi.org\/10.1186\/s12967-022-03837-2.","journal-title":"J Transl Med"},{"key":"490_CR97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijbiomac.2022.11.324","volume":"226","author":"X Lai","year":"2023","unstructured":"Lai X, Huang S, Lin Y, Qiu Y, Pu L, Lin S, et al. DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts. Int J Biol Macromol. 2023;226:291\u2013300. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.324.","journal-title":"Int J Biol Macromol"},{"key":"490_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.174976","volume":"949","author":"Y Xie","year":"2024","unstructured":"Xie Y, Yang S, Xu Y, Gu P, Zhang Y, You X, et al. Interleukin-11 drives fibroblast metabolic reprogramming in crystalline silica-induced lung fibrosis. Sci Total Environ. 2024;949:174976. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.174976.","journal-title":"Sci Total Environ"},{"issue":"2","key":"490_CR99","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1165\/rcmb.2016-0186OC","volume":"58","author":"J Goodwin","year":"2018","unstructured":"Goodwin J, Choi H, Hsieh MH, Neugent ML, Ahn JM, Hayenga HN, et al. Targeting Hypoxia-Inducible Factor-1\u03b1\/Pyruvate Dehydrogenase Kinase 1 axis by Dichloroacetate suppresses Bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2018;58(2):216\u201331. https:\/\/doi.org\/10.1165\/rcmb.2016-0186OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"490_CR100","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12931-019-1058-2","volume":"20","author":"E Schruf","year":"2019","unstructured":"Schruf E, Schroeder V, Kuttruff CA, Weigle S, Krell M, Benz M, et al. Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis. Respir Res. 2019;20(1):87. https:\/\/doi.org\/10.1186\/s12931-019-1058-2.","journal-title":"Respir Res"},{"key":"490_CR101","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-026-02476-9","author":"X Mo","year":"2026","unstructured":"Mo X, Yao H, Ju H, Wang M, Yi M, Lu Y, et al. PKM2 promotes glycolysis in alveolar macrophages and induces inflammation in Bronchopulmonary Dysplasia. Inflammation. 2026. https:\/\/doi.org\/10.1007\/s10753-026-02476-9.","journal-title":"Inflammation"},{"key":"490_CR102","doi-asserted-by":"publisher","unstructured":"Liu Z, Liu W, Wei H, Ping Y, Yu Z, Dong Z, et al. Elevated lactate production exacerbates PM2.5-induced pulmonary fibrosis by stabilizing TGF-\u03b21. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.07.057","DOI":"10.1016\/j.jare.2025.07.057"},{"issue":"1","key":"490_CR103","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1165\/rcmb.2020-0360OC","volume":"64","author":"H Cui","year":"2021","unstructured":"Cui H, Xie N, Banerjee S, Ge J, Jiang D, Dey T, et al. Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation. Am J Respir Cell Mol Biol. 2021;64(1):115\u201325. https:\/\/doi.org\/10.1165\/rcmb.2020-0360OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"490_CR104","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12931-023-02644-7","volume":"25","author":"R Summer","year":"2024","unstructured":"Summer R, Todd JL, Neely ML, Lobo LJ, Namen A, Newby LK, et al. Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Respir Res. 2024;25(1):58. https:\/\/doi.org\/10.1186\/s12931-023-02644-7.","journal-title":"Respir Res"},{"issue":"2","key":"490_CR105","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1165\/rcmb.2023-0290OC","volume":"71","author":"J Liang","year":"2024","unstructured":"Liang J, Huang G, Liu X, Zhang X, Rabata A, Liu N, et al. Lipid deficiency contributes to impaired alveolar progenitor cell function in aging and Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2024;71(2):242\u201353. https:\/\/doi.org\/10.1165\/rcmb.2023-0290OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"490_CR106","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12931-024-02816-z","volume":"25","author":"J Yang","year":"2024","unstructured":"Yang J, Pan X, Xu M, Li Y, Liang C, Liu L, et al. Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts. Respir Res. 2024;25(1):176. https:\/\/doi.org\/10.1186\/s12931-024-02816-z.","journal-title":"Respir Res"},{"issue":"1","key":"490_CR107","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12931-023-02629-6","volume":"24","author":"D Kwak","year":"2023","unstructured":"Kwak D, Bradley PB, Subbotina N, Ling S, Teitz-Tennenbaum S, Osterholzer JJ, et al. CD36\/Lyn kinase interactions within macrophages promotes pulmonary fibrosis in response to oxidized phospholipid. Respir Res. 2023;24(1):314. https:\/\/doi.org\/10.1186\/s12931-023-02629-6.","journal-title":"Respir Res"},{"issue":"10","key":"490_CR108","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1038\/s41401-025-01558-y","volume":"46","author":"HQ Wan","year":"2025","unstructured":"Wan HQ, Xie LF, Li HL, Ma Y, Li QH, Dai MQ, et al. GPR40 activation alleviates pulmonary fibrosis by repressing M2 macrophage polarization through the PKD1\/CD36\/TGF-\u03b21 pathway. Acta Pharmacol Sin. 2025;46(10):2707\u201322. https:\/\/doi.org\/10.1038\/s41401-025-01558-y.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"490_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166960","volume":"1870","author":"L Wang","year":"2024","unstructured":"Wang L, Yuan H, Li W, Yan P, Zhao M, Li Z, et al. ACSS3 regulates the metabolic homeostasis of epithelial cells and alleviates pulmonary fibrosis. Biochim Biophys Acta Mol Basis Dis. 2024;1870(2):166960. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166960.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"490_CR110","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41420-025-02715-2","volume":"11","author":"H Zheng","year":"2025","unstructured":"Zheng H, Zhang L, Wang C, Wang Y, Zeng C. Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. Cell Death Discov. 2025;11(1):411. https:\/\/doi.org\/10.1038\/s41420-025-02715-2.","journal-title":"Cell Death Discov"},{"key":"490_CR111","doi-asserted-by":"publisher","unstructured":"Contento G, Wilson JA, Selvarajah B, Plat\u00e9 M, Guillotin D, Morales V, et al. Pyruvate metabolism dictates fibroblast sensitivity to GLS1 inhibition during fibrogenesis. JCI Insight. 2024;9(18). https:\/\/doi.org\/10.1172\/jci.insight.178453","DOI":"10.1172\/jci.insight.178453"},{"key":"490_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050728","author":"S Wang","year":"2022","unstructured":"Wang S, Li X, Ma Q, Wang Q, Wu J, Yu H, et al. Glutamine metabolism is required for alveolar regeneration during lung injury. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12050728.","journal-title":"Biomolecules"},{"issue":"1","key":"490_CR113","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/toxsci\/kfac089","volume":"190","author":"G Li","year":"2022","unstructured":"Li G, Xu Q, Cheng D, Sun W, Liu Y, Ma D, et al. Caveolin-1 and Its Functional Peptide CSP7 Affect Silica-Induced Pulmonary Fibrosis by Regulating Fibroblast Glutaminolysis. Toxicol Sci. 2022;190(1):41\u201353. https:\/\/doi.org\/10.1093\/toxsci\/kfac089.","journal-title":"Toxicol Sci"},{"key":"490_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101655","volume":"67","author":"Z Xiang","year":"2023","unstructured":"Xiang Z, Bai L, Zhou JQ, Cevallos RR, Sanders JR, Liu G, et al. Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis. Mol Metab. 2023;67:101655. https:\/\/doi.org\/10.1016\/j.molmet.2022.101655.","journal-title":"Mol Metab"},{"key":"490_CR115","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.freeradbiomed.2021.10.006","volume":"176","author":"H Shaghaghi","year":"2021","unstructured":"Shaghaghi H, Para R, Tran C, Roman J, Ojeda-Lassalle Y, Sun J, et al. Glutamine restores mitochondrial respiration in bleomycin-injured epithelial cells. Free Radic Biol Med. 2021;176:335\u201344. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.10.006.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"490_CR116","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20(10):633\u201346. https:\/\/doi.org\/10.1038\/s41575-023-00807-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"490_CR117","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","volume":"33","author":"P Trivedi","year":"2021","unstructured":"Trivedi P, Wang S, Friedman SL. The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells. Cell Metab. 2021;33(2):242\u201357. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.026.","journal-title":"Cell Metab"},{"key":"490_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107990","volume":"221","author":"Y Shang","year":"2025","unstructured":"Shang Y, Sun Q, Xin X, Wang Z, Gao S, Lin R, et al. The role of glycolysis in MASLD development: Pathogenesis and therapeutic strategies. Pharmacol Res. 2025;221:107990. https:\/\/doi.org\/10.1016\/j.phrs.2025.107990.","journal-title":"Pharmacol Res"},{"issue":"8","key":"490_CR119","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","volume":"35","author":"H Rho","year":"2023","unstructured":"Rho H, Terry AR, Chronis C, Hay N. Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab. 2023;35(8):1406-1423.e1408. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.013.","journal-title":"Cell Metab"},{"issue":"19","key":"490_CR120","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1111\/bph.14768","volume":"176","author":"Z Loh","year":"2019","unstructured":"Loh Z, Fitzsimmons RL, Reid RC, Ramnath D, Clouston A, Gupta PK, et al. Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation. Br J Pharmacol. 2019;176(19):3775\u201390. https:\/\/doi.org\/10.1111\/bph.14768.","journal-title":"Br J Pharmacol"},{"key":"490_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122498","volume":"341","author":"X Wu","year":"2024","unstructured":"Wu X, Shen Y, Meng Y, Chen J, Zhang Y, Zeng S, et al. Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis. Life Sci. 2024;341:122498. https:\/\/doi.org\/10.1016\/j.lfs.2024.122498.","journal-title":"Life Sci"},{"issue":"1","key":"490_CR122","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","volume":"159","author":"M Mejias","year":"2020","unstructured":"Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, et al. CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis. Gastroenterology. 2020;159(1):273\u201388. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.008.","journal-title":"Gastroenterology"},{"issue":"11","key":"490_CR123","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.ajpath.2020.08.002","volume":"190","author":"D Zheng","year":"2020","unstructured":"Zheng D, Jiang Y, Qu C, Yuan H, Hu K, He L, et al. Pyruvate kinase M2 tetramerization protects against hepatic stellate cell activation and liver fibrosis. Am J Pathol. 2020;190(11):2267\u201381. https:\/\/doi.org\/10.1016\/j.ajpath.2020.08.002.","journal-title":"Am J Pathol"},{"issue":"9","key":"490_CR124","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","volume":"55","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity. 2022;55(9):1515\u201329. https:\/\/doi.org\/10.1016\/j.immuni.2022.08.002.","journal-title":"Immunity"},{"issue":"12","key":"490_CR125","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","volume":"71","author":"J Rao","year":"2022","unstructured":"Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei S, et al. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut. 2022;71(12):2539\u201350. https:\/\/doi.org\/10.1136\/gutjnl-2021-325150.","journal-title":"Gut"},{"key":"490_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101634","volume":"36","author":"F Xu","year":"2020","unstructured":"Xu F, Guo M, Huang W, Feng L, Zhu J, Luo K, et al. Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biol. 2020;36:101634. https:\/\/doi.org\/10.1016\/j.redox.2020.101634.","journal-title":"Redox Biol"},{"issue":"3","key":"490_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115350","volume":"44","author":"J Li","year":"2025","unstructured":"Li J, Chen X, Song S, Jiang W, Geng T, Wang T, et al. Hexokinase 2-mediated metabolic stress and inflammation burden of liver macrophages via histone lactylation in MASLD. Cell Rep. 2025;44(3):115350. https:\/\/doi.org\/10.1016\/j.celrep.2025.115350.","journal-title":"Cell Rep"},{"issue":"1","key":"490_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45167-5","volume":"15","author":"T Dong","year":"2024","unstructured":"Dong T, Hu G, Fan Z, Wang H, Gao Y, Wang S, et al. Activation of GPR3-\u03b2-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis. Nat Commun. 2024;15(1):807. https:\/\/doi.org\/10.1038\/s41467-024-45167-5.","journal-title":"Nat Commun"},{"key":"490_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1651923","volume":"16","author":"Q Xia","year":"2025","unstructured":"Xia Q, Sun D, Wan K, Liu C, Shu H, Wang M, et al. Lactylation: the metabolic-immune hub in autoimmune diseases. Front Immunol. 2025;16:1651923. https:\/\/doi.org\/10.3389\/fimmu.2025.1651923.","journal-title":"Front Immunol"},{"issue":"3","key":"490_CR130","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/hep.0000000000000569","volume":"79","author":"F Wang","year":"2024","unstructured":"Wang F, Chen L, Kong D, Zhang X, Xia S, Liang B, et al. Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1\u03b1 transcriptional complex. Hepatology. 2024;79(3):606\u201323. https:\/\/doi.org\/10.1097\/hep.0000000000000569.","journal-title":"Hepatology"},{"key":"490_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154759","volume":"114","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou Y, Xia S, Chen L, Yang T, Zhao D, et al. Blockade of KLF5\/LDH-A feedback loop contributes to Curcumol inhibition of sinusoidal endothelial cell glycolysis and mitigation of liver fibrosis. Phytomedicine. 2023;114:154759. https:\/\/doi.org\/10.1016\/j.phymed.2023.154759.","journal-title":"Phytomedicine"},{"issue":"1","key":"490_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0324-8","volume":"17","author":"F Wang","year":"2019","unstructured":"Wang F, Jia Y, Li M, Wang L, Shao J, Guo Q, et al. Blockade of glycolysis-dependent contraction by Oroxylin A via inhibition of lactate dehydrogenase-A in hepatic stellate cells. Cell Commun Signal. 2019;17(1):11. https:\/\/doi.org\/10.1186\/s12964-019-0324-8.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"490_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2025.101896","volume":"30","author":"I Irshad","year":"2025","unstructured":"Irshad I, Alqahtani SA, Ikejima K, Yu ML, Romero-Gomez M, Eslam M. Energy metabolism: An emerging therapeutic frontier in liver fibrosis. Ann Hepatol. 2025;30(1):101896. https:\/\/doi.org\/10.1016\/j.aohep.2025.101896.","journal-title":"Ann Hepatol"},{"issue":"5","key":"490_CR134","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.7150\/thno.106597","volume":"15","author":"M Yan","year":"2025","unstructured":"Yan M, Cui Y, Xiang Q. Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. Theranostics. 2025;15(5):1715\u201340. https:\/\/doi.org\/10.7150\/thno.106597.","journal-title":"Theranostics"},{"issue":"5","key":"490_CR135","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1053\/j.gastro.2025.03.010","volume":"169","author":"T Kisseleva","year":"2025","unstructured":"Kisseleva T, Ganguly S, Murad R, Wang A, Brenner DA. Regulation of hepatic stellate cell phenotypes in Metabolic Dysfunction-Associated Steatohepatitis. Gastroenterology. 2025;169(5):797\u2013812. https:\/\/doi.org\/10.1053\/j.gastro.2025.03.010.","journal-title":"Gastroenterology"},{"key":"490_CR136","doi-asserted-by":"publisher","unstructured":"Guillot A, Tacke F. Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context. Hepatol Commun. 2024;8(7). https:\/\/doi.org\/10.1097\/hc9.0000000000000491","DOI":"10.1097\/hc9.0000000000000491"},{"key":"490_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512032","author":"E Vassiliou","year":"2023","unstructured":"Vassiliou E, Farias-Pereira R. Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241512032.","journal-title":"Int J Mol Sci"},{"key":"490_CR138","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001371","author":"C Ma","year":"2025","unstructured":"Ma C, Wang S, Dong B, Tian Y. Metabolic reprogramming of immune cells in MASH. Hepatology. 2025. https:\/\/doi.org\/10.1097\/hep.0000000000001371.","journal-title":"Hepatology"},{"issue":"2","key":"490_CR139","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","volume":"83","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms. J Hepatol. 2025;83(2):584\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2025.02.033.","journal-title":"J Hepatol"},{"issue":"11","key":"490_CR140","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-022-05409-0","volume":"13","author":"X Yin","year":"2022","unstructured":"Yin X, Peng J, Gu L, Liu Y, Li X, Wu J, et al. Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis. Cell Death Dis. 2022;13(11):955. https:\/\/doi.org\/10.1038\/s41419-022-05409-0.","journal-title":"Cell Death Dis"},{"issue":"9","key":"490_CR141","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1016\/j.apsb.2022.03.014","volume":"12","author":"F Wang","year":"2022","unstructured":"Wang F, Li Z, Chen L, Yang T, Liang B, Zhang Z, et al. Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1\u03b1\/NF-\u03baB feedback pathway to inhibit liver fibrosis. Acta Pharm Sin B. 2022;12(9):3618\u201338. https:\/\/doi.org\/10.1016\/j.apsb.2022.03.014.","journal-title":"Acta Pharm Sin B"},{"key":"490_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.117511","volume":"289","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zeng Y, Ying H, Hong Y, Xu J, Lin R, et al. AdipoRon mitigates liver fibrosis by suppressing serine\/glycine biosynthesis through ATF4-dependent glutaminolysis. Ecotoxicol Environ Saf. 2025;289:117511. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117511.","journal-title":"Ecotoxicol Environ Saf"},{"key":"490_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2025.102132","volume":"96","author":"R Huang","year":"2025","unstructured":"Huang R, Cui H, Alshami YAMA, Fu C, Jiang W, Cai M, et al. LOX-1 rewires glutamine ammonia metabolism to drive liver fibrosis. Mol Metab. 2025;96:102132. https:\/\/doi.org\/10.1016\/j.molmet.2025.102132.","journal-title":"Mol Metab"},{"issue":"1","key":"490_CR144","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8(1):129. https:\/\/doi.org\/10.1038\/s41392-023-01379-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"490_CR145","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol. 2022;18(9):545\u201357. https:\/\/doi.org\/10.1038\/s41581-022-00590-z.","journal-title":"Nat Rev Nephrol"},{"issue":"7841","key":"490_CR146","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe C, Ibrahim MM, Kranz J, Zhang X, Ziegler S, Perales-Pat\u00f3n J, et al. Decoding myofibroblast origins in human kidney fibrosis. Nature. 2021;589(7841):281\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2941-1.","journal-title":"Nature"},{"key":"490_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121033","volume":"312","author":"X Wei","year":"2023","unstructured":"Wei X, Hou Y, Long M, Jiang L, Du Y. Advances in energy metabolism in renal fibrosis. Life Sci. 2023;312:121033. https:\/\/doi.org\/10.1016\/j.lfs.2022.121033.","journal-title":"Life Sci"},{"issue":"1","key":"490_CR148","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41581-024-00889-z","volume":"21","author":"V Miguel","year":"2025","unstructured":"Miguel V, Shaw IW, Kramann R. Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat Rev Nephrol. 2025;21(1):39\u201356. https:\/\/doi.org\/10.1038\/s41581-024-00889-z.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"490_CR149","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.kint.2024.04.016","volume":"106","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-\u03baB family activation. Kidney Int. 2024;106(2):226\u201340. https:\/\/doi.org\/10.1016\/j.kint.2024.04.016.","journal-title":"Kidney Int"},{"key":"490_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1259434","volume":"14","author":"Q Yang","year":"2023","unstructured":"Yang Q, Huo E, Cai Y, Zhang Z, Dong C, Asara JM, et al. Myeloid PFKFB3-mediated glycolysis promotes kidney fibrosis. Front Immunol. 2023;14:1259434. https:\/\/doi.org\/10.3389\/fimmu.2023.1259434.","journal-title":"Front Immunol"},{"issue":"4","key":"490_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04803-y","volume":"13","author":"C Song","year":"2022","unstructured":"Song C, Wang S, Fu Z, Chi K, Geng X, Liu C, et al. IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis. Cell Death Dis. 2022;13(4):340. https:\/\/doi.org\/10.1038\/s41419-022-04803-y.","journal-title":"Cell Death Dis"},{"key":"490_CR152","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000000000488","author":"Y Huang","year":"2024","unstructured":"Huang Y, Cong A, Li J, Zhou Z, Zhou H, Su C, et al. Glycolysis in peritubular endothelial cells and microvascular rarefaction in CKD. J Am Soc Nephrol. 2024. https:\/\/doi.org\/10.1681\/asn.0000000000000488.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"490_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06347-1","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Wu H, Li Y, Li L, Xiang J, Kang L, et al. Inhibition of PFKP in renal tubular epithelial cell restrains TGF-\u03b2 induced glycolysis and renal fibrosis. Cell Death Dis. 2023;14(12):816. https:\/\/doi.org\/10.1038\/s41419-023-06347-1.","journal-title":"Cell Death Dis"},{"issue":"10","key":"490_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05305-7","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Cheuk YC, Jia Y, Chen T, Chen J, Luo Y, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM. Cell Death Dis. 2022;13(10):876. https:\/\/doi.org\/10.1038\/s41419-022-05305-7.","journal-title":"Cell Death Dis"},{"issue":"2","key":"490_CR155","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.kint.2022.03.024","volume":"102","author":"M Gu","year":"2022","unstructured":"Gu M, Tan M, Zhou L, Sun X, Lu Q, Wang M, et al. Protein phosphatase 2Ac\u03b1 modulates fatty acid oxidation and glycolysis to determine tubular cell fate and kidney injury. Kidney Int. 2022;102(2):321\u201336. https:\/\/doi.org\/10.1016\/j.kint.2022.03.024.","journal-title":"Kidney Int"},{"key":"490_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119206","volume":"272","author":"H Yu","year":"2021","unstructured":"Yu H, Zhu J, Chang L, Liang C, Li X, Wang W. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model. Life Sci. 2021;272:119206. https:\/\/doi.org\/10.1016\/j.lfs.2021.119206.","journal-title":"Life Sci"},{"issue":"3","key":"490_CR157","doi-asserted-by":"publisher","first-page":"F561","DOI":"10.1152\/ajprenal.00036.2017","volume":"313","author":"H Ding","year":"2017","unstructured":"Ding H, Jiang L, Xu J, Bai F, Zhou Y, Yuan Q, et al. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. Am J Physiol Renal Physiol. 2017;313(3):F561-f575. https:\/\/doi.org\/10.1152\/ajprenal.00036.2017.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"490_CR158","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.kint.2020.03.035","volume":"98","author":"H Cao","year":"2020","unstructured":"Cao H, Luo J, Zhang Y, Mao X, Wen P, Ding H, et al. Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis. Kidney Int. 2020;98(3):686\u201398. https:\/\/doi.org\/10.1016\/j.kint.2020.03.035.","journal-title":"Kidney Int"},{"key":"490_CR159","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129034","author":"J Li","year":"2020","unstructured":"Li J, Liu H, Takagi S, Nitta K, Kitada M, Srivastava SP, et al. Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.129034.","journal-title":"JCI Insight"},{"key":"490_CR160","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179871","author":"SY Li","year":"2024","unstructured":"Li SY, Tsai MT, Kuo YM, Yang HM, Tong ZJ, Cheng HW, et al. Aldehyde dehydrogenase 2 preserves kidney function by countering acrolein-induced metabolic and mitochondrial dysfunction. JCI Insight. 2024. https:\/\/doi.org\/10.1172\/jci.insight.179871.","journal-title":"JCI Insight"},{"key":"490_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155592","volume":"145","author":"C Xu","year":"2023","unstructured":"Xu C, Hong Q, Zhuang K, Ren X, Cui S, Dong Z, et al. Regulation of pericyte metabolic reprogramming restricts the AKI to CKD transition. Metabolism. 2023;145:155592. https:\/\/doi.org\/10.1016\/j.metabol.2023.155592.","journal-title":"Metabolism"},{"issue":"1","key":"490_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04167-7","volume":"21","author":"L Chen","year":"2023","unstructured":"Chen L, Li X, Deng Y, Chen J, Huang M, Zhu F, et al. The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII. J Transl Med. 2023;21(1):323. https:\/\/doi.org\/10.1186\/s12967-023-04167-7.","journal-title":"J Transl Med"},{"key":"490_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107407","author":"JQ Hu","year":"2024","unstructured":"Hu JQ, Zheng DC, Huang L, Yang X, Ning CQ, Zhou J, et al. Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming. Pharmacol Res. 2024. https:\/\/doi.org\/10.1016\/j.phrs.2024.107407.","journal-title":"Pharmacol Res"},{"key":"490_CR164","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00513.2018","author":"ER Smith","year":"2019","unstructured":"Smith ER, Wigg B, Holt S, Hewitson TD. TGF-\u03b21 modifies histone acetylation and acetyl-coenzyme A metabolism in renal myofibroblasts. Am J Physiol Renal Physiol. 2019. https:\/\/doi.org\/10.1152\/ajprenal.00513.2018.","journal-title":"Am J Physiol Renal Physiol"},{"key":"490_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155957","volume":"158","author":"W Zhu","year":"2024","unstructured":"Zhu W, Guo S, Sun J, Zhao Y, Liu C. Lactate and lactylation in cardiovascular diseases: current progress and future perspectives. Metabolism. 2024;158:155957. https:\/\/doi.org\/10.1016\/j.metabol.2024.155957.","journal-title":"Metabolism"},{"key":"490_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103246","volume":"75","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S, et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la\/KLF5 pathway. Redox Biol. 2024;75:103246. https:\/\/doi.org\/10.1016\/j.redox.2024.103246.","journal-title":"Redox Biol"},{"issue":"1","key":"490_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74919-8","volume":"10","author":"ER Smith","year":"2020","unstructured":"Smith ER, Hewitson TD. TGF-\u03b21 is a regulator of the pyruvate dehydrogenase complex in fibroblasts. Sci Rep. 2020;10(1):17914. https:\/\/doi.org\/10.1038\/s41598-020-74919-8.","journal-title":"Sci Rep"},{"issue":"9","key":"490_CR168","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41419-021-04134-4","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wen P, Luo J, Ding H, Cao H, He W, et al. Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death Dis. 2021;12(9):847. https:\/\/doi.org\/10.1038\/s41419-021-04134-4.","journal-title":"Cell Death Dis"},{"issue":"6","key":"490_CR169","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1681\/asn.0000000000000328","volume":"35","author":"H Chen","year":"2024","unstructured":"Chen H, You R, Guo J, Zhou W, Chew G, Devapragash N, et al. WWP2 regulates renal fibrosis and the metabolic reprogramming of profibrotic myofibroblasts. J Am Soc Nephrol. 2024;35(6):696\u2013718. https:\/\/doi.org\/10.1681\/asn.0000000000000328.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"490_CR170","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.cmet.2022.09.026","volume":"34","author":"H Li","year":"2022","unstructured":"Li H, Dixon EE, Wu H, Humphreys BD. Comprehensive single-cell transcriptional profiling defines shared and unique epithelial injury responses during kidney fibrosis. Cell Metab. 2022;34(12):1977-1998.e1979. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.026.","journal-title":"Cell Metab"},{"issue":"10","key":"490_CR171","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19(10):629\u201345. https:\/\/doi.org\/10.1038\/s41581-023-00741-w.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"490_CR172","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","volume":"106","author":"LE Lee","year":"2024","unstructured":"Lee LE, Doke T, Mukhi D, Susztak K. The key role of altered tubule cell lipid metabolism in kidney disease development. Kidney Int. 2024;106(1):24\u201334. https:\/\/doi.org\/10.1016\/j.kint.2024.02.025.","journal-title":"Kidney Int"},{"issue":"4","key":"490_CR173","doi-asserted-by":"publisher","first-page":"F444","DOI":"10.1152\/ajprenal.00168.2025","volume":"329","author":"NH Garcia","year":"2025","unstructured":"Garcia NH, Gaivin RJ, Khan S, Li V, Rbaibi Y, Weisz OA, et al. Fatty acids and albumin are transported by distinct mechanisms in the proximal tubule. Am J Physiol Renal Physiol. 2025;329(4):F444-f451. https:\/\/doi.org\/10.1152\/ajprenal.00168.2025.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"490_CR174","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2015;21(1):37\u201346. https:\/\/doi.org\/10.1038\/nm.3762.","journal-title":"Nat Med"},{"issue":"Pt 4","key":"490_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146856","volume":"322","author":"A Pandi","year":"2025","unstructured":"Pandi A, Sen N, Kalappan VM. Fatty acid transport protein 2: A novel therapeutic target in lipid metabolism and disease - A review. Int J Biol Macromol. 2025;322(Pt 4):146856. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146856.","journal-title":"Int J Biol Macromol"},{"key":"490_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155991","volume":"134","author":"J Wang","year":"2024","unstructured":"Wang J, Wang L, Feng X, Xu Y, Zhou L, Wang C, et al. Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2. Phytomedicine. 2024;134:155991. https:\/\/doi.org\/10.1016\/j.phymed.2024.155991.","journal-title":"Phytomedicine"},{"issue":"1","key":"490_CR177","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1038\/s41467-022-32972-z","volume":"13","author":"PC Wilson","year":"2022","unstructured":"Wilson PC, Muto Y, Wu H, Karihaloo A, Waikar SS, Humphreys BD. Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression. Nat Commun. 2022;13(1):5253. https:\/\/doi.org\/10.1038\/s41467-022-32972-z.","journal-title":"Nat Commun"},{"key":"490_CR178","doi-asserted-by":"publisher","DOI":"10.1172\/jci165654","author":"S Mohandes","year":"2023","unstructured":"Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K. Molecular pathways that drive diabetic kidney disease. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/jci165654.","journal-title":"J Clin Invest"},{"issue":"2","key":"490_CR179","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ymthe.2024.12.053","volume":"33","author":"X Li","year":"2025","unstructured":"Li X, Chen J, Li J, Zhang Y, Xia J, Du H, et al. ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD. Mol Ther. 2025;33(2):805\u201322. https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.053.","journal-title":"Mol Ther"},{"key":"490_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155978","volume":"159","author":"S Zhou","year":"2024","unstructured":"Zhou S, Ling X, Liang Y, Feng Q, Xie C, Li J, et al. Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells. Metabolism. 2024;159:155978. https:\/\/doi.org\/10.1016\/j.metabol.2024.155978.","journal-title":"Metabolism"},{"issue":"3","key":"490_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167656","volume":"1871","author":"P Sun","year":"2025","unstructured":"Sun P, Chen Q, Chen X, Zhou J, Long T, Ma Y, et al. Renal tubular S100A7a impairs fatty acid oxidation and exacerbates renal fibrosis via both intracellular and extracellular pathway. Biochim Biophys Acta Mol Basis Dis. 2025;1871(3):167656. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167656.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"490_CR182","doi-asserted-by":"publisher","first-page":"1669557","DOI":"10.3389\/fnut.2025.1669557","volume":"12","author":"J Sun","year":"2025","unstructured":"Sun J, Yin C, Li Z, Gao X, Li S, Gao H, et al. Natural compounds regulating fatty acid oxidation in the treatment of diabetic kidney disease. Front Nutr. 2025;12:1669557. https:\/\/doi.org\/10.3389\/fnut.2025.1669557.","journal-title":"Front Nutr"},{"key":"490_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112303","volume":"135","author":"J Jia","year":"2024","unstructured":"Jia J, Tan R, Xu L, Wang H, Li J, Su H, et al. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3\/NOX4\/SLC7A11 signaling-mediated tubular cell ferroptosis. Int Immunopharmacol. 2024;135:112303. https:\/\/doi.org\/10.1016\/j.intimp.2024.112303.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"490_CR184","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/imna-d-24-00027","volume":"11","author":"YH Liu","year":"2024","unstructured":"Liu YH. Kidney fibrosis: fundamental questions, challenges, and perspectives. Integr Med Nephrol Androl. 2024;11(4):4. https:\/\/doi.org\/10.1097\/imna-d-24-00027.","journal-title":"Integr Med Nephrol Androl"},{"issue":"12","key":"490_CR185","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-024-00872-8","volume":"20","author":"MGE Knol","year":"2024","unstructured":"Knol MGE, Wulfmeyer VC, M\u00fcller RU, Rinschen MM. Amino acid metabolism in kidney health and disease. Nat Rev Nephrol. 2024;20(12):771\u201388. https:\/\/doi.org\/10.1038\/s41581-024-00872-8.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"490_CR186","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41584-024-01217-2","volume":"21","author":"DJ Abraham","year":"2025","unstructured":"Abraham DJ, Black CM, Denton CP, Distler JHW, Domsic R, Feghali-Bostwick C, et al. An international perspective on the future of systemic sclerosis research. Nat Rev Rheumatol. 2025;21(3):174\u201387. https:\/\/doi.org\/10.1038\/s41584-024-01217-2.","journal-title":"Nat Rev Rheumatol"},{"issue":"766","key":"490_CR187","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn7871","volume":"16","author":"DJ Li","year":"2024","unstructured":"Li DJ, Berry CE, Wan DC, Longaker MT. Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis. Sci Transl Med. 2024;16(766):eadn7871. https:\/\/doi.org\/10.1126\/scitranslmed.adn7871.","journal-title":"Sci Transl Med"},{"issue":"4","key":"490_CR188","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.apsb.2025.02.007","volume":"15","author":"L Guo","year":"2025","unstructured":"Guo L, Xiang W, Pan Z, Gu H, Jiang X. Post-translational modifications of collagen and its related diseases in metabolic pathways. Acta Pharm Sin B. 2025;15(4):1773\u201395. https:\/\/doi.org\/10.1016\/j.apsb.2025.02.007.","journal-title":"Acta Pharm Sin B"},{"key":"490_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.12.002","author":"S Marella","year":"2026","unstructured":"Marella S, Plikus MV, Gudjonsson JE. Skin fibroblasts in health and disease: from extracellular matrix remodeling to immune regulation. J Invest Dermatol. 2026. https:\/\/doi.org\/10.1016\/j.jid.2025.12.002.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"490_CR190","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41584-025-01349-z","volume":"22","author":"JHW Distler","year":"2026","unstructured":"Distler JHW, Launay D, Feghali-Bostwick C, Matei AE, Trojanowska M, Gudjonsson JE. Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis. Nat Rev Rheumatol. 2026;22(4):221\u201338. https:\/\/doi.org\/10.1038\/s41584-025-01349-z.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"490_CR191","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jid.2025.09.006","volume":"146","author":"Z Ghasemishahrestani","year":"2026","unstructured":"Ghasemishahrestani Z, Khumalo NP, Ipp H, Bayat A. Cutaneous immune memory: a double-edged sword in skin repair and fibrosis. J Invest Dermatol. 2026;146(3):625\u201339. https:\/\/doi.org\/10.1016\/j.jid.2025.09.006.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"490_CR192","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-025-02113-2","volume":"23","author":"F Yu","year":"2025","unstructured":"Yu F, Chen J, Wang X, Hou S, Li H, Yao Y, et al. Metabolic reprogramming of peritoneal mesothelial cells in peritoneal dialysis-associated fibrosis: therapeutic targets and strategies. Cell Commun Signal. 2025;23(1):114. https:\/\/doi.org\/10.1186\/s12964-025-02113-2.","journal-title":"Cell Commun Signal"},{"key":"490_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27052199","author":"T Jasi\u0144ski","year":"2026","unstructured":"Jasi\u0144ski T, Koz\u0142owska N, Zdrojkowski \u0141, Br\u0119borowicz A, Rey B, Domino M. The role of NF-\u03baB in peritoneal fibrosis and adhesion in humans and animals: A systematic review. Int J Mol Sci. 2026. https:\/\/doi.org\/10.3390\/ijms27052199.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"490_CR194","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1053\/j.gastro.2025.06.010","volume":"169","author":"S Ferreira-Gonzalez","year":"2025","unstructured":"Ferreira-Gonzalez S, Matsumoto T, Hara E, Forbes SJ. Senescence, aging and disease throughout the gastrointestinal system. Gastroenterology. 2025;169(7):1357\u201379. https:\/\/doi.org\/10.1053\/j.gastro.2025.06.010.","journal-title":"Gastroenterology"},{"issue":"7","key":"490_CR195","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41573-025-01158-9","volume":"24","author":"F Rieder","year":"2025","unstructured":"Rieder F, Nagy LE, Maher TM, Distler JHW, Kramann R, Hinz B, et al. Fibrosis: cross-organ biology and pathways to development of innovative drugs. Nat Rev Drug Discov. 2025;24(7):543\u201369. https:\/\/doi.org\/10.1038\/s41573-025-01158-9.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"490_CR196","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410416","volume":"12","author":"X Di","year":"2025","unstructured":"Di X, Li Y, Wei J, Li T, Liao B. Targeting fibrosis: from molecular mechanisms to advanced therapies. Adv Sci. 2025;12(3):e2410416. https:\/\/doi.org\/10.1002\/advs.202410416.","journal-title":"Adv Sci"},{"issue":"11","key":"490_CR197","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/ckj\/sfad085","volume":"16","author":"CVC Junho","year":"2023","unstructured":"Junho CVC, Frisch J, Soppert J, Wollenhaupt J, Noels H. Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology. Clin Kidney J. 2023;16(11):1786\u2013803. https:\/\/doi.org\/10.1093\/ckj\/sfad085.","journal-title":"Clin Kidney J"},{"issue":"11","key":"490_CR198","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/circresaha.124.325488","volume":"136","author":"H Noels","year":"2025","unstructured":"Noels H, van der Vorst EPC, Rubin S, Emmett A, Marx N, Tomaszewski M, et al. Renal-cardiac crosstalk in the pathogenesis and progression of heart failure. Circ Res. 2025;136(11):1306\u201334. https:\/\/doi.org\/10.1161\/circresaha.124.325488.","journal-title":"Circ Res"},{"issue":"7","key":"490_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2025.05.007","volume":"10","author":"AC Park","year":"2025","unstructured":"Park AC, Schilling JD. The cardiohepatic axis in heart failure. JACC Basic Transl Sci. 2025;10(7):101312. https:\/\/doi.org\/10.1016\/j.jacbts.2025.05.007.","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"490_CR200","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","volume":"165","author":"JJ Wattacheril","year":"2023","unstructured":"Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ. AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review. Gastroenterology. 2023;165(4):1080\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2023.06.013.","journal-title":"Gastroenterology"},{"key":"490_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01220-4","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, Mehta A, Goh R, Koh J, Chen Y, Chong B, et al. The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges. Nat Rev Cardiol. 2025. https:\/\/doi.org\/10.1038\/s41569-025-01220-4.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"490_CR202","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/circulationaha.124.070535","volume":"151","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, Mehta A, Goh RSJ, Zhang A, Chen Y, Chong B, et al. Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach. Circulation. 2025;151(1):98\u2013119. https:\/\/doi.org\/10.1161\/circulationaha.124.070535.","journal-title":"Circulation"},{"key":"490_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.07.016","author":"W Liu","year":"2025","unstructured":"Liu W, Wu X, Zeng W, Chandy M, Wu JC. Cardiac fibrosis: from mechanisms and models to medicines. Trends Pharmacol Sci. 2025. https:\/\/doi.org\/10.1016\/j.tips.2025.07.016.","journal-title":"Trends Pharmacol Sci"},{"key":"490_CR204","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2024.06.001","volume":"222","author":"V Miguel","year":"2024","unstructured":"Miguel V, Alcalde-Est\u00e9vez E, Sirera B, Rodr\u00edguez-Pascual F, Lamas S. Metabolism and bioenergetics in the pathophysiology of organ fibrosis. Free Radic Biol Med. 2024;222:85\u2013105. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.06.001.","journal-title":"Free Radic Biol Med"},{"key":"490_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112269","volume":"135","author":"P Tiwari","year":"2024","unstructured":"Tiwari P, Verma S, Washimkar KR, Nilakanth Mugale M. Immune cells crosstalk pathways, and metabolic alterations in idiopathic pulmonary fibrosis. Int Immunopharmacol. 2024;135:112269. https:\/\/doi.org\/10.1016\/j.intimp.2024.112269.","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"490_CR206","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj3289","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang J, Zhang J, Wang Y, Wang Y, Kang H, et al. Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis. Sci Adv. 2024;10(23):eadj3289. https:\/\/doi.org\/10.1126\/sciadv.adj3289.","journal-title":"Sci Adv"},{"issue":"8038","key":"490_CR207","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","volume":"635","author":"JM Amrute","year":"2024","unstructured":"Amrute JM, Luo X, Penna V, Yang S, Yamawaki T, Hayat S, et al. Targeting immune-fibroblast cell communication in heart failure. Nature. 2024;635(8038):423\u201333. https:\/\/doi.org\/10.1038\/s41586-024-08008-5.","journal-title":"Nature"},{"issue":"4","key":"490_CR208","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41418-024-01266-w","volume":"31","author":"J Luo","year":"2024","unstructured":"Luo J, Li P, Dong M, Zhang Y, Lu S, Chen M, et al. SLC15A3 plays a crucial role in pulmonary fibrosis by regulating macrophage oxidative stress. Cell Death Differ. 2024;31(4):417\u201330. https:\/\/doi.org\/10.1038\/s41418-024-01266-w.","journal-title":"Cell Death Differ"},{"issue":"12","key":"490_CR209","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/circresaha.124.325212","volume":"135","author":"J Wang","year":"2024","unstructured":"Wang J, Du H, Xie W, Bi J, Zhang H, Liu X, et al. CAR-Macrophage therapy alleviates myocardial ischemia-reperfusion injury. Circ Res. 2024;135(12):1161\u201374. https:\/\/doi.org\/10.1161\/circresaha.124.325212.","journal-title":"Circ Res"},{"key":"490_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155913","volume":"155","author":"X Zhao","year":"2024","unstructured":"Zhao X, Li Y, Yu J, Teng H, Wu S, Wang Y, et al. Role of mitochondria in pathogenesis and therapy of renal fibrosis. Metabolism. 2024;155:155913. https:\/\/doi.org\/10.1016\/j.metabol.2024.155913.","journal-title":"Metabolism"},{"key":"490_CR211","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2025","author":"CR Kliment","year":"2026","unstructured":"Kliment CR, Gurkar AU, C\u00e1rdenes N, Ramonell R, Finkel T, K\u00f6nigshoff M. Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease. Physiol Rev. 2026. https:\/\/doi.org\/10.1152\/physrev.00024.2025.","journal-title":"Physiol Rev"},{"key":"490_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2025.104983","volume":"143","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang Y, Guo X, Xiao Y, Wan W, Zou H, et al. Mitochondrial dysfunction in fibrotic diseases: research progress and MSC-exos therapy. Exp Mol Pathol. 2025;143:104983. https:\/\/doi.org\/10.1016\/j.yexmp.2025.104983.","journal-title":"Exp Mol Pathol"},{"key":"490_CR213","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2026.1767822","volume":"17","author":"X Jin","year":"2026","unstructured":"Jin X, Ma Y, Tang Y, Qiao F, Xiao T, Cui Y, et al. Research trends of mitochondrial dysfunction in hepatic fibrosis: a bibliometric analysis. Front Physiol. 2026;17:1767822. https:\/\/doi.org\/10.3389\/fphys.2026.1767822.","journal-title":"Front Physiol"},{"issue":"6","key":"490_CR214","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","volume":"15","author":"X Fan","year":"2024","unstructured":"Fan X, Yang M, Lang Y, Lu S, Kong Z, Gao Y, et al. Mitochondrial metabolic reprogramming in diabetic kidney disease. Cell Death Dis. 2024;15(6):442. https:\/\/doi.org\/10.1038\/s41419-024-06833-0.","journal-title":"Cell Death Dis"},{"key":"490_CR215","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020949","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yang J, Zhang Y, Zhou J. Focus on mitochondrial respiratory chain: Potential therapeutic target for chronic renal failure. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25020949.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"490_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104519","volume":"30","author":"K Zhang","year":"2025","unstructured":"Zhang K, Zhang E, Wu K, Cheng W, Wei S. Mitochondrial homeostasis: a key regulator in endometrial physiology and pathology. Drug Discov Today. 2025;30(12):104519. https:\/\/doi.org\/10.1016\/j.drudis.2025.104519.","journal-title":"Drug Discov Today"},{"key":"490_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1412672","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Liu W, Luo Z, Xiao F, Sun B. New insights into the roles of lactylation in cancer. Front Pharmacol. 2024;15:1412672. https:\/\/doi.org\/10.3389\/fphar.2024.1412672.","journal-title":"Front Pharmacol"},{"issue":"Pt 3","key":"490_CR218","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.semcancer.2022.10.009","volume":"86","author":"J Lin","year":"2022","unstructured":"Lin J, Liu G, Chen L, Kwok HF, Lin Y. Targeting lactate-related cell cycle activities for cancer therapy. Semin Cancer Biol. 2022;86(Pt 3):1231\u201343. https:\/\/doi.org\/10.1016\/j.semcancer.2022.10.009.","journal-title":"Semin Cancer Biol"},{"issue":"8021","key":"490_CR219","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, Li Y, Li H, Chen X, Fu H, Mao D, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631(8021):663\u20139. https:\/\/doi.org\/10.1038\/s41586-024-07620-9.","journal-title":"Nature"},{"issue":"8","key":"490_CR220","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s41401-024-01264-1","volume":"45","author":"X Ni","year":"2024","unstructured":"Ni X, Lu CP, Xu GQ, Ma JJ. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy. Acta Pharmacol Sin. 2024;45(8):1533\u201355. https:\/\/doi.org\/10.1038\/s41401-024-01264-1.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"490_CR221","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1039\/d2cs00479h","volume":"52","author":"J Chen","year":"2023","unstructured":"Chen J, Zhu Y, Wu C, Shi J. Engineering lactate-modulating nanomedicines for cancer therapy. Chem Soc Rev. 2023;52(3):973\u20131000. https:\/\/doi.org\/10.1039\/d2cs00479h.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"490_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50242-y","volume":"15","author":"J Bie","year":"2024","unstructured":"Bie J, Li R, Li Y, Song C, Chen Z, Zhang T, et al. PKM2 aggregation drives metabolism reprograming during aging process. Nat Commun. 2024;15(1):5761. https:\/\/doi.org\/10.1038\/s41467-024-50242-y.","journal-title":"Nat Commun"},{"issue":"10","key":"490_CR223","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/13543776.2024.2403616","volume":"34","author":"S Adem","year":"2024","unstructured":"Adem S, Rasul A, Riaz S, Sadiqa A, Ahmad M, Shahid Nazir M, et al. Pyruvate kinase modulators as a therapy target: an updated patent review 2018\u20132023. Expert Opin Ther Pat. 2024;34(10):953\u201362. https:\/\/doi.org\/10.1080\/13543776.2024.2403616.","journal-title":"Expert Opin Ther Pat"},{"key":"490_CR224","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5429","author":"Q Liu","year":"2024","unstructured":"Liu Q, Li J, Li X, Zhang L, Yao S, Wang Y, et al. Advances in the understanding of the role and mechanism of action of PFKFB3\u2011mediated glycolysis in liver fibrosis (review). Int J Mol Med. 2024. https:\/\/doi.org\/10.3892\/ijmm.2024.5429.","journal-title":"Int J Mol Med"},{"issue":"15","key":"490_CR225","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","volume":"383","author":"CP Cannon","year":"2020","unstructured":"Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, et al. Cardiovascular outcomes with Ertugliflozin in type 2 diabetes. N Engl J Med. 2020;383(15):1425\u201335. https:\/\/doi.org\/10.1056\/NEJMoa2004967.","journal-title":"N Engl J Med"},{"issue":"3","key":"490_CR226","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/dom.14923","volume":"25","author":"KD Corbin","year":"2023","unstructured":"Corbin KD, Dagogo-Jack S, Cannon CP, Cherney DZI, Cosentino F, Frederich R, et al. Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin. Diabetes Obes Metab. 2023;25(3):758\u201366. https:\/\/doi.org\/10.1111\/dom.14923.","journal-title":"Diabetes Obes Metab"},{"key":"490_CR227","doi-asserted-by":"publisher","DOI":"10.1172\/jci164486","author":"JA Schaub","year":"2023","unstructured":"Schaub JA, AlAkwaa FM, McCown PJ, Naik AS, Nair V, Eddy S, et al. SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/jci164486.","journal-title":"J Clin Invest"},{"issue":"5","key":"490_CR228","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","volume":"21","author":"L Abbad","year":"2025","unstructured":"Abbad L, Esteve E, Chatziantoniou C. Advances and challenges in kidney fibrosis therapeutics. Nat Rev Nephrol. 2025;21(5):314\u201329. https:\/\/doi.org\/10.1038\/s41581-025-00934-5.","journal-title":"Nat Rev Nephrol"},{"key":"490_CR229","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01992-2018","author":"PT Lukey","year":"2019","unstructured":"Lukey PT, Harrison SA, Yang S, Man Y, Holman BF, Rashidnasab A, et al. A randomised, placebo-controlled study of omipalisib (PI3K\/mTOR) in idiopathic pulmonary fibrosis. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.01992-2018.","journal-title":"Eur Respir J"},{"issue":"6","key":"490_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2025.100824","volume":"66","author":"M Kalyesubula","year":"2025","unstructured":"Kalyesubula M, Von Bank H, Davidson JW, Burhans MS, Becker MM, Aljohani A, et al. Stearoyl-CoA desaturase 1 deficiency drives saturated lipid accumulation and increases liver and plasma acylcarnitines. J Lipid Res. 2025;66(6):100824. https:\/\/doi.org\/10.1016\/j.jlr.2025.100824.","journal-title":"J Lipid Res"},{"issue":"10","key":"490_CR231","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","volume":"27","author":"V Ratziu","year":"2021","unstructured":"Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, et al. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat Med. 2021;27(10):1825\u201335. https:\/\/doi.org\/10.1038\/s41591-021-01495-3.","journal-title":"Nat Med"},{"issue":"2","key":"490_CR232","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/hep.31622","volume":"73","author":"R Loomba","year":"2021","unstructured":"Loomba R, Noureddin M, Kowdley KV, Kohli A, Sheikh A, Neff G, et al. Combination therapies including Cilofexor and Firsocostat for bridging fibrosis and cirrhosis attributable to NASH. Hepatology. 2021;73(2):625\u201343. https:\/\/doi.org\/10.1002\/hep.31622.","journal-title":"Hepatology"},{"issue":"5","key":"490_CR233","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","volume":"161","author":"R Loomba","year":"2021","unstructured":"Loomba R, Mohseni R, Lucas KJ, Gutierrez JA, Perry RG, Trotter JF, et al. TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial. Gastroenterology. 2021;161(5):1475\u201386. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.025.","journal-title":"Gastroenterology"},{"issue":"2","key":"490_CR234","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","volume":"54","author":"TM Davis","year":"2011","unstructured":"Davis TM, Ting R, Best JD, Donoghoe MW, Drury PL, Sullivan DR, et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia. 2011;54(2):280\u201390. https:\/\/doi.org\/10.1007\/s00125-010-1951-1.","journal-title":"Diabetologia"},{"key":"490_CR235","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jare.2024.04.029","volume":"70","author":"B Shan","year":"2025","unstructured":"Shan B, Guo C, Zhou H, Chen J. Tanshinone IIA alleviates pulmonary fibrosis by modulating glutamine metabolic reprogramming based on [U-(13)C(5)]-glutamine metabolic flux analysis. J Adv Res. 2025;70:531\u201344. https:\/\/doi.org\/10.1016\/j.jare.2024.04.029.","journal-title":"J Adv Res"},{"issue":"7","key":"490_CR236","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216940","volume":"15","author":"I Yoon","year":"2023","unstructured":"Yoon I, Kim S, Cho M, You KA, Son J, Lee C, et al. Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1. EMBO Mol Med. 2023;15(7):e16940. https:\/\/doi.org\/10.15252\/emmm.202216940.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"490_CR237","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.32255","volume":"75","author":"A Jain","year":"2022","unstructured":"Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, et al. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: a double-blind randomized controlled trial. Hepatology. 2022;75(5):1194\u2013203. https:\/\/doi.org\/10.1002\/hep.32255.","journal-title":"Hepatology"},{"key":"490_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155587","volume":"144","author":"M Guo","year":"2023","unstructured":"Guo M, Liu D, Jiang Y, Chen W, Zhao L, Bao D, et al. Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis. Metabolism. 2023;144:155587. https:\/\/doi.org\/10.1016\/j.metabol.2023.155587.","journal-title":"Metabolism"},{"key":"490_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105264","volume":"107","author":"AC Pouleur","year":"2024","unstructured":"Pouleur AC, Menghoum N, Cumps J, Marino A, Badii M, Lejeune S, et al. Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project. EBioMedicine. 2024;107:105264. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105264.","journal-title":"EBioMedicine"},{"issue":"44","key":"490_CR240","doi-asserted-by":"publisher","first-page":"24285","DOI":"10.1021\/acs.analchem.5c00277","volume":"97","author":"X Liu","year":"2025","unstructured":"Liu X, Zhao Y, Xie Y, Shi Y, Yang J, Du Y, et al. Characterization of lipid epi-metabolites\/reactions as diagnostic biomarkers for idiopathic pulmonary fibrosis by Lipidepifind. Anal Chem. 2025;97(44):24285\u201394. https:\/\/doi.org\/10.1021\/acs.analchem.5c00277.","journal-title":"Anal Chem"},{"issue":"1","key":"490_CR241","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06975-5","volume":"23","author":"W Cai","year":"2025","unstructured":"Cai W, Zhang H, Li Z, Cai M, Chen P, Guo N, et al. Potential biomarkers of idiopathic pulmonary fibrosis: metabonomics driven lipid profiling. J Transl Med. 2025;23(1):1010. https:\/\/doi.org\/10.1186\/s12967-025-06975-5.","journal-title":"J Transl Med"},{"key":"490_CR242","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2025.09.029","volume":"241","author":"O Chalifoux","year":"2025","unstructured":"Chalifoux O, Dagostino C, Li M, Trezza S, Grayson C, De Sa Tavares Russo M, et al. Accumulation of succinate in the blood is a potential early indicator of metabolic dysfunction-associated steatotic liver disease (MASLD). Free Radic Biol Med. 2025;241:220\u201335. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.09.029.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"490_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102522","volume":"7","author":"Y Huang","year":"2026","unstructured":"Huang Y, Li J, Song S, Du B, Cao Y, Wang Y, et al. Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLD. Cell Rep Med. 2026;7(1):102522. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102522.","journal-title":"Cell Rep Med"},{"issue":"1","key":"490_CR244","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00555-9","volume":"12","author":"CR Yang","year":"2024","unstructured":"Yang CR, Lin WJ, Shen PC, Liao PY, Dai YC, Hung YC, et al. Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis. Biomark Res. 2024;12(1):6. https:\/\/doi.org\/10.1186\/s40364-023-00555-9.","journal-title":"Biomark Res"},{"issue":"1","key":"490_CR245","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41581-025-01008-2","volume":"22","author":"A Vlahou","year":"2026","unstructured":"Vlahou A, Vanholder R. Urine as a source of biomarkers and biological knowledge in chronic kidney disease. Nat Rev Nephrol. 2026;22(1):69\u201384. https:\/\/doi.org\/10.1038\/s41581-025-01008-2.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"490_CR246","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf380","volume":"19","author":"P Heneberg","year":"2026","unstructured":"Heneberg P, Heneberg \u0160im\u010d\u00edkov\u00e1 D. Untangling amino acid metabolism in renal diseases: mechanisms, dysregulation, and critical gaps. Clin Kidney J. 2026;19(2):sfaf380. https:\/\/doi.org\/10.1093\/ckj\/sfaf380.","journal-title":"Clin Kidney J"},{"issue":"9","key":"490_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100599","volume":"65","author":"P Seubnooch","year":"2024","unstructured":"Seubnooch P, Montani M, Dufour JF, Masoodi M. Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in metabolic dysfunction-associated steatohepatitis. J Lipid Res. 2024;65(9):100599. https:\/\/doi.org\/10.1016\/j.jlr.2024.100599.","journal-title":"J Lipid Res"},{"issue":"11","key":"490_CR248","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.792","volume":"5","author":"S Pan","year":"2024","unstructured":"Pan S, Yin L, Liu J, Tong J, Wang Z, Zhao J, et al. Metabolomics-driven approaches for identifying therapeutic targets in drug discovery. MedComm (2020). 2024;5(11):e792. https:\/\/doi.org\/10.1002\/mco2.792.","journal-title":"MedComm (2020)"},{"issue":"1","key":"490_CR249","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68464-7","volume":"17","author":"X Wang","year":"2026","unstructured":"Wang X, Liu Y, Jiang C, Huang Z, Yan H, Wong SH, et al. TidyMass2: advancing LC-MS untargeted metabolomics through metabolite origin inference and metabolic feature-based functional module analysis. Nat Commun. 2026;17(1):1755. https:\/\/doi.org\/10.1038\/s41467-026-68464-7.","journal-title":"Nat Commun"},{"issue":"11","key":"490_CR250","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1161\/circresaha.125.325496","volume":"136","author":"SK Mohanta","year":"2025","unstructured":"Mohanta SK, Heron C, Klaus-Bergmann A, Horstmann H, Brakenhielm E, Giannarelli C, et al. Metabolic and immune crosstalk in cardiovascular disease. Circ Res. 2025;136(11):1433\u201353. https:\/\/doi.org\/10.1161\/circresaha.125.325496.","journal-title":"Circ Res"},{"key":"490_CR251","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29061298","author":"B Paj\u0105k","year":"2024","unstructured":"Paj\u0105k B, Zieli\u0144ski R, Priebe W. The impact of glycolysis and its inhibitors on the immune response to inflammation and autoimmunity. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29061298.","journal-title":"Molecules"},{"issue":"1","key":"490_CR252","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07642-6","volume":"22","author":"AN Bhatt","year":"2022","unstructured":"Bhatt AN, Shenoy S, Munjal S, Chinnadurai V, Agarwal A, Vinoth Kumar A, et al. 2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial. BMC Infect Dis. 2022;22(1):669. https:\/\/doi.org\/10.1186\/s12879-022-07642-6.","journal-title":"BMC Infect Dis"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00490-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00490-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00490-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:35:41Z","timestamp":1780659341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00490-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":252,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00490-9","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}